Abstract

We have used S1 and primer extension analysis to demonstrate that the gene for bovine beta 1----4-galactosyltransferase specifies two sets of mRNA transcripts of different lengths. The longer mRNA transcripts initiate upstream of two in-frame ATG codons and encode a protein of 402 amino acids (long form). The shorter mRNA transcripts initiate between the two in-frame ATG codons and encode a protein of 389 amino acids (short form). These two related forms of beta 1----4-galactosyltransferase have an identical large (358 amino acids), potentially glycosylated, COOH-terminal catalytic domain, and an identical single transmembrane domain. The only difference in primary structure between the two forms is that the long form contains an NH2-terminal extension of 13 amino acids. Thus, bovine beta 1----4-galactosyltransferase fits the pattern established for murine beta 1----4-galactosyltransferase (Shaper, N. L., Hollis, G. L., Douglas, J. G., Kirsch, I. R., and Shaper, J. H. (1988) J. Biol. Chem. 263, 10420-10428). Inspection of the NH2-terminal domain suggests that the long form of the bovine enzyme, like its murine counterpart, has a functional cleavable signal sequence which would dictate that the two forms of the membrane-bound enzyme are oriented in opposite directions. We have tested this hypothesis by in vitro translation in the absence or presence of dog pancreas microsomes. In vitro translation of RNA transcripts for the long and short form of beta 1----4-galactosyltransferase in the absence of microsomes results in the synthesis of polypeptides with apparent Mr of 44,500 and 43,000, respectively. In vitro translation of each transcript in the presence of microsomes results in the synthesis of two glycosylated, endoglycosidase H-sensitive proteins with apparent Mr of 47,500 and 46,000. These experiments and additional protease protection experiments demonstrate that the COOH-terminal domain of both the short and the long form of bovine beta 1----4-galactosyltransferase are translocated into the microsomal lumen. By extrapolation, both forms of the enzyme are oriented in vivo as Type II membrane-bound glycoproteins.

Highlights

  • From the $Cell Structure and Function Laboratory, The Oncology Center und the $Department Sciences, School of Medicine, The Joh.ns Hopkins University, Baltimore, Maryland 21205 of Pharmacology and Molecular

  • We have used Sl and primer extension analysis to demonstrate that the gene for bovine @l-4-gala&osyltransferase specifies two sets of mRNA transcripts of different lengths

  • The only difference in primary strutture between the two forms is that the long form contains an NHZ-terminal extension of 13 amino acids, bovine @l-4-galactosyltransferase fits the pattern established for murine @1+4-galactosyltransferase

Read more

Summary

PROCEDURES

In Shaper et al (1988). The vector pGEM3 and all reagents for the in &ro transcription and translation experiments were purchased from Promega Biotec, Inc. Primer extension analysis was carried out essentially as described (Shaper et al, 1988), using a 200-bp radiolabeled primer complementary to nucleotides 231 to 407 of bovine fll-&galactosyltransferase (Fig. 1) that included 24 bp of Ml3 sequence. Plasmids containing inserts in the sense and antisense orientation with respect to the SP6 promoter were linearized with PuuII prior to transcription. Clone 44 and clone 7A were ligated at the unique S&I &te (nucleotide position 226, Fig. l), and the resulting 1544-bp fragment was ligated into the EcoRI site of pGEM3, yielding pSGT which encodes the short form of pl+4-. Plasmids containing the insert in the sense and antisense orientation with respect to the SP6 promoter were linearized with BgZI and treated, just prior to transcription, with the Klenow fragment of DNA polymerase I in order to convert the. Gels were fixed in 50% methanol, 16% acetic acid, treated with fluorographic enhancer, dried, and placed under film at -70 -C

RESULTS
Procedures”
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.